Cargando…

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015

INTRODUCTION: Existing research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Postabortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Studnicki, James, Harrison, Donna J., Longbons, Tessa, Skop, Ingrid, Reardon, David C., Fisher, John W., Tsulukidze, Maka, Craver, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581786/ https://www.ncbi.nlm.nih.gov/pubmed/34778493 http://dx.doi.org/10.1177/23333928211053965

Ejemplares similares

Estimating the Period Prevalence of Mothers Who Have Abortions: A Population Based Study of Inclusive Pregnancy Outcomes
por: Studnicki, James, et al.
Publicado: (2021)

The Enduring Association of a First Pregnancy Abortion with Subsequent Pregnancy Outcomes: A Longitudinal Cohort Study
por: Studnicki, James, et al.
Publicado: (2022)

A Cohort Study of Mental Health Services Utilization Following a First Pregnancy Abortion or Birth
por: Studnicki, James, et al.
Publicado: (2023)

A Post Hoc Exploratory Analysis: Induced Abortion Complications Mistaken for Miscarriage in the Emergency Room are a Risk Factor for Hospitalization
por: Studnicki, J., et al.
Publicado: (2022)

Estimating the Period Prevalence of Publicly Funded Abortion to Space Live Births, 1999 to 2014
por: Studnicki, James, et al.
Publicado: (2021)

Pregnancy Outcome Patterns of Medicaid-Eligible Women, 1999-2014: A National Prospective Longitudinal Study
por: Studnicki, James, et al.
Publicado: (2020)

Doctors Who Perform Abortions: Their Characteristics and Patterns of Holding and Using Hospital Privileges
por: Studnicki, James, et al.
Publicado: (2019)

Elevated cardiovascular disease risk in low-income women with a history of pregnancy loss
por: Tsulukidze, Maka, et al.
Publicado: (2022)

Effects of Pressure to Abort on Women’s Emotional Responses and Mental Health
por: Reardon, David C, et al.
Publicado: (2023)

EXPRESSION OF CONCERN: A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions
Publicado: (2023)

The Effects of Abortion Decision Rightness and Decision Type on Women’s Satisfaction and Mental Health
por: Reardon, David C, et al.
Publicado: (2023)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States
por: Mark, Alice, et al.
Publicado: (2021)

Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation
por: Løkeland, Mette, et al.
Publicado: (2014)

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
por: Wiebe, Ellen R, et al.
Publicado: (2020)

Dispensing mifepristone for medical abortion in Canada: Pharmacists’ experiences of the first year
por: Zusman, Enav Z., et al.
Publicado: (2023)

Mifepristone Antagonization with Progesterone to Avert Medication Abortion: A Scoping Review
por: DeBeasi, Paul L. C.
Publicado: (2023)

Perceiving and Addressing the Pervasive Racial Disparity in Abortion
por: Studnicki, James, et al.
Publicado: (2020)

Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostol
por: Song, Li‐Ping, et al.
Publicado: (2018)

Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: Zhao, Xiaoying, et al.
Publicado: (2021)

Subsequent placenta accreta after previous mifepristone-induced abortion: A case report
por: Zhao, Peng, et al.
Publicado: (2021)

Pharmacist checklist and resource guide for mifepristone medical abortion: User-centred development and testing
por: Rebic, Nevena, et al.
Publicado: (2021)

Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists
por: Zusman, Enav Z, et al.
Publicado: (2022)

The efficacy and influence factors analysis of Mifepristone combined with estrogen-progesterone in the treatment of incomplete abortion
por: Wang, Kai, et al.
Publicado: (2022)

Retracted: Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Effects of Pregnancy Loss on Subsequent Postpartum Mental Health: A Prospective Longitudinal Cohort Study
por: Reardon, David C., et al.
Publicado: (2021)

Late-Term Abortion and Medical Necessity: A Failure of Science
por: Studnicki, James
Publicado: (2019)

Determination of Mifepristone (RU-486) and Its Metabolites in Maternal Blood Sample after Pharmacological Abortion
por: Szpot, Paweł, et al.
Publicado: (2022)

Intervals and Outcomes of First and Second Pregnancies in Low-Income Women: A Record-Linkage Longitudinal Prospective Cohort Study
por: Reardon, David C., et al.
Publicado: (2021)

Trends in medication abortion and the role of low-volume and nonmetropolitan mifepristone purchasers: 2008–2011 and 2014–2017()
por: Jones, Rachel K.
Publicado: (2020)

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion
por: Chinery, Lester, et al.
Publicado: (2020)

Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers
por: Devane, Courtney, et al.
Publicado: (2019)

A cross-sectional retrospective analysis of the regionalization of complex surgery
por: Studnicki, James, et al.
Publicado: (2014)

Patients Covertly Recording Clinical Encounters: Threat or Opportunity? A Qualitative Analysis of Online Texts
por: Tsulukidze, Maka, et al.
Publicado: (2015)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

A Retrospective Cost-Effectiveness Analysis of Mifepristone–Misoprostol Medical Abortions in the First Year at the Regina General Hospital
por: Hunter, Caitlin, et al.
Publicado: (2021)

Clinical Outcomes and Women’s Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa
por: Constant, Deborah, et al.
Publicado: (2016)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
por: Shimels, Tariku, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_212urfgt8c47okmgjm64gcjn26